Super eugeroic 'armodafinil' (Nuvigil), by modafinil’s creator, Cephalon, is FDA-approved. Ampakine CX717 from Cortex is in clinical trials. Both drugs promise even longer periods of wakefulness.
Armodafinil (Nuvigil®) is an eugeroic drug made by Cephalon, FDA-approved 6/15/2007. Clinical trials for its use in bipolar disorder, cognition in schizophrenia, excessive fatigue in Parkinson's & cancer, begin. Patent expires 2023.
Armodafinil From Wikipedia, the free encyclopedia Jump to: navigation, search Armodafinil Systematic (IUPAC) name (-)-2-[(R)-(diphenylmethyl)sulfinyl]acetamide Identifiers CAS number 68693-11-8 ATC code N06BA07 PubChem ? Chemical data Formu
Even the lowest dose of modafinil, an ampakine, improved the wakefulness and cognitive performance of sleep-deprived people; they work in part by boosting glutamate, a key neurotransmitter that facilitates learning & learn and encodes memory.
For narcolepsy, or off-label for depression, night-shift work, ADHD/ADD...a prodrug, metabolizes to modafinil (Provigil®), resulting in nearly identical pharmacological effects, takes 45-60 minutes to reach active levels in bloodstream.
Provigil (generic name modafinil) is an eugeroic drug generally prescribed to treat narcolepsy. Eugeroic simply means ‘good arousal’. This unique class of drug contains only two at present, Adrafinil and Modafinil. Modafinil is not a typical stimulant